Please use this identifier to cite or link to this item:
Full metadata record
|dc.contributor.author||Abbott, Anne L||en|
|dc.contributor.author||Levi, Christopher R||en|
|dc.contributor.author||Chambers, Brian R||en|
|dc.identifier.citation||International Journal of Stroke : Official Journal of the International Stroke Society; 2(1): 27-39||en|
|dc.description.abstract||The benefit of prophylactic carotid endarterectomy (CEA) for patients with asymptomatic severe carotid stenosis in the major randomised surgical studies was small, expensive and may now be absorbed by improvements in best practice medical intervention. Strategies to identify patients with high stroke risk are needed. If surgical intervention is to be considered the complication rates of individual surgeons should be available. Clinicians will differ in their interpretation of the same published data. Maintaining professional relationships with clinicians from different disciplines often involves compromise. As such, the management of a patient will, in part, depend on what kind of specialist the patient is referred to. The clinician's discussion with patients about this complex issue must be flexible to accommodate differing patient expectations. Ideally, patients prepared to undergo surgical procedures should be monitored in a trial setting or as part of an audited review process to increase our understanding of current practice outcomes.||en|
|dc.subject.other||Randomized Controlled Trials as Topic||en|
|dc.title||What should we do with asymptomatic carotid stenosis?||en|
|dc.identifier.journaltitle||International Journal of Stroke||en|
|dc.identifier.affiliation||National Stroke Research Institute, Austin Health, Heidelberg, Victoria, Australia 3081, Australia||en|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.